Metabolic Dysfunction-Associated Steatotic Liver Disease Linked to Risk for Sudden Hearing Loss
By Elana Gotkine HealthDay Reporter
FRIDAY, June 20, 2025 -- Among older adults, metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with increased risk for sudden sensorineural hearing loss (SSNHL), according to a study published in the June issue of Laryngoscope: Investigative Otolaryngology.
Eun Seok Kang, M.D., from the Korea University College of Medicine in Seoul, and colleagues conducted a population-based cohort study using the Korean National Health Insurance Service-Senior cohort involving 189,623 participants aged 65 years or older who were categorized as non-SLD or MASLD. The risk for SSNHL and Meniere disease was examined.
The researchers found that compared with the non-SLD group, participants with MASLD had higher metabolic dysfunction markers, including elevated body mass index, waist circumference, and blood pressure. There were 3,803 SSNHL events in the MASLD group during nine years of follow-up, with an incidence rate of 2.44 per 1,000 person-years. MASLD was associated with a significantly increased risk for SSNHL after inverse probability of treatment weighting (adjusted hazard ratio, 1.05; subdistribution hazard ratio, 1.06).
"This finding serves as an important indicator that reflects the impact of MASLD on disease progression from a prognostic perspective, rather than merely examining the occurrence of the disease itself," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
FRIDAY, June 20, 2025 -- For patients aged 45 years or older with type 2 diabetes, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and...
Likelihood of Psych Disorders Lower With Weight-Loss Surgery Versus GLP-1 RAs
FRIDAY, June 20, 2025 -- People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated with glucagon-like peptide-1...
Marine Microplastic Levels Linked to Cardiometabolic Disease Prevalence
WEDNESDAY, June 18, 2025 -- In coastal counties, marine microplastic levels (MMLs) are associated with the prevalence of cardiometabolic diseases, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.